11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets: A microdissection-based genotyping approach useful in clinical practice

American Journal of Pathology

Volumn 155, Issue 2, 1999, Pages 633-640

  Finkelstein, Sydney D ^a,c   Hasegawa, Tsuyoshi ^a   Colby, Thomas ^b   Yousem, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CARCINOID; CHROMOSOME 11Q; CLINICAL ARTICLE; CONTROLLED STUDY; DISSECTION; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG TUMOR; METHODOLOGY; MICROSCOPY; PRIORITY JOURNAL; TUMOR DIAGNOSIS;

EID: 0032788103     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65159-0     Document Type: Article

References (43)

1. Vuitch F, Sekido Y, Fong K, Mackay B, Minna JD, Gazdar AF: Neuroendocrine tumors of the lung. Pathology and molecular biology. Chest Surg Clin North Am 1997, 7:21-47
2. Marchevsky AM: Neuroendocrine tumors of the lung. Pathology 1996, 4:103-123
3. Pearson PL, Van der Luijt RB: The genetic analysis of cancer. J Intern Med 1998, 243:413-417
4. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski M, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Speigel AM, Burns AL, Marx SJ: Positional cloning of the gene for multiple endocrine neoplasia-Type 1. Science 1997, 276:404-406
5. Lemmens I, Van de Ven WJM, Kas Koen, Zhang CX, Giraud S, Wautot V, Buisson N, Witte KD, Salabdre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, Wit MJD, Lips CJM, Hoppener JWM, Khodaei S, Grant AL, Weber G, Kytola S, The BT, Farnebo F, Phelan C, Haywood N, Larsson C, Pannett AAJ, Forbes SA, Bassett JHD, Thakker RV: Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1997, 6:1177-1183
6. Bale AE, Norton JA, Wong EL, Fryburg JS, Maton PN, Oldfield EH, Streeten E, Aurbach GD, Brandi ML, Friedman E, Spiegel AM, Taggart RT, Marx SJ: Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res 1991, 51:1154-1157
7. Eng C: The RET proto-oncogene in multiple endocrine neoplasia type 2, and Hirschsprung's disease in Seminars in Medicine of the Beth Israel Hospital. New Engl J Med 1996, 335:943-951
8. Anonymous: The search for the MEN1 gene. The European Consortium on MEN-1. J Intern Med 1998, 243:441-446
9. Kovatich A, Friedland DM, Druck T, Hadeczek P, Huebner K, Comis RL, Hauck W, McCue PA: Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors. Cancer 1998, 83:1109-1117
10. Cagle PT, EI-Naggar AK, Xu H-J, Hu S-X, Benedict WF: Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Am J Pathol 1997, 150:393-400
11. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL, Brambilla C: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer 1994, 58:818-824
12. Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL: Apoptosis-related factors p53, Bcl2, and bax in neuroendocrine lung tumors. Am J Pathol 1996, 149:1941-1952
13. Roncalli M, Doglioni C, Springall DR, Papotti M, Pagani A, Polak JM, Ibrahim NBN, Coggi G, Viale G: Abnormal p53 expression in lung neuroendocrine tumors. Diagn Mol Pathol 1992, 1:129-135
14. Hiyama K, Hasegawa K, Ishioka S, Takahashi N, Yamakido M: An atypical carcinoid tumor of the lung with mutations in the p53 gene and the retinoblastoma gene. Chest 1993, 104:1606-1607
15. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guineee DG, Koss M, Travis WD: Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Am J Pathol 1996, 148:1531-1541
16. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, Green JS, Gum SC, Manickam P, Olufemi SE, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ: Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997, 6:1169-1175
17. Bassett JHD, Forbes SA, Pannett AAJ, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JAH, Wheeler MH, Thakker RV: Characterization of mutations in patients with multiple endocrine neoplasia Type 1. Am J Hum Genet 1998, 62:232-244
18. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT, Liotta LA, Lubensky IA: The multiple endocrine neoplasia type 1 gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997, 113:773-781
19. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru S, Manickam P, Olulemi SE, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997, 6:2285-2290
20. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 1993,90:10914-10921
21. Elias JM: Introduction of the genetics of cancer. Cell Vision 1998, 5:37-42
22. Finkelstein SD, Swalsky PA, Przygodzki RM: Microdissection-based p53 genotyping: concepts for molecular testing. Mol Diagn 1998, 3:179-191
23. Rao U, Swalsky PA, Bakker A, Finkelstein SD: Desmoplastic melanoma. Mod Pathol 1999, 12:344-350
24. Yoshida MC, Wada M, Satoh H, and Yoshida T: Human HST1 (HSTF1) gene maps to chromosome band 11q13, and coamplifies with the NT2 gene in human cancer. Proc Natl Acad Sci USA 1988, 85:4861-4864
25. Polymeropoulos MH, Xiao H, Rath DS, Merril CR: Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2). Nucleic Acids Res 1990, 18:7468
26. Meyers SL, Dudley JP: Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas. Mol Carcinog 1992, 6:243-251
27. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA: Genotypic classification of colorectal adenocarcinoma. Cancer 1993, 71:3827-3838
28. Finkelstein SD, Przygodzki RM, Pricolo VE, Sakallah SA, Swalsky PA, Bakker A, Lanning R, Bland KI, Cooper DL: Prediction of biological aggressiveness in colorectal cancer by p53/k-ras-2 topographic genotyping. Mol Diagn 1996, 1:5-28
29. Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martinez AJ, Sherwin RN, Bozik ME, Gollin SM: The relationship between mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 1997, 57:304-309
30. Kounelis S, Jones MW, Papadaki H, Bakker A, Swalsky PA, Finkelstein SD: Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum Pathol 1998, 29:82-87
31. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Dun FM, Lubensky IA, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman Ml, Zbar B, Linehan WM: Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet 1994, 7:85-90
32. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms; tumor. Cell 1990, 61:1257-1269
33. Hahn M, Fislage R, Pingoud A: Polymorphism of the pentanucleotide repeat d(AAAAT) within intron 1 of the human tumor suppressor gene p53 (17p13.1). Hum Genet 1994, 93:222
34. Dressen JC, Bras M, Coonen E, Dumoulin JC, Evers JL, Geraedts JP: Allelic dropout caused by allele-specific amplification failure in single-cell PCR of the cystic fibrosis delta F508 deletion. J Assist Reprod Genet 1996, 13:112-114
35. Rechitsky S, Freidine M, Verlinsky Y, Strom CM: Allele dropout in sequential PCR and FISH analysis of single cells (cell recycling). J Assist Reprod Genet 1996, 13:115-124
36. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson J, Myers EN, Gollin SM: Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosom Cancer 1995, 12:288-295
37. Bale SJ, Bale AE, Stewart K, Dachowski L: Lingake analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11. Genomics 1989, 4:320-322
38. Pauley RJ, Gimotty PA, Paine TJ, Dawson PJ: INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes. Breast Cancer Res Treat 1996, 37:65-76
39. Debelenko LV, Zhuang, Z, Emmert-Buck, MR, Settara C, Chandrasekharappa SC, Manickam P, Guru SC, Marx SJ, Skarulis MC, Spiegel AM, Collins FS, Jensen RT, Liotta LA, Lubinsky IA: Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 1997, 57:2238-2243
40. Dong Q, Debelenko LV, Chandrasekharappa SC, Emmert-Buck, MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS. Spiegel AM, Burns AL, Marx SJ: Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 1997, 82:1416-1420
41. Landegren U, Nilsson M, Kwok PY: Reading bits of genetic information: methods for single nucleotide polymorphism analysis. Genome Res 1998, 8:769-776
42. Walch AK, Zitzelsberger HF, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Prauer HW, Werner M, Hofler H: Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 1998, 153:1089-1098
43. Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, Hasleton P, Gazdar AF: Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999, 85:600-607